Imunon, Inc. — Director's Dealing 2021

Mar 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2021-03-19

Reporting Person: Tardugno Michael H (Director, Chairman, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-19	Option to Purchase Celsion Corporation Common Stock	$2.24	A	650000	Acquired	2031-03-19	Celsion Corporation Common Stock (650000)	Direct

Footnotes

F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.

F2: The options vest as follows: 1/3 immediately, 1/3 on the first anniversary of the date of grant and 1/3 on the second year anniversary of the date of grant.